Ribosomal protein L31 pseudogene 59 (RPL31P59)

RPL31P59 (ribosomal protein L31 pseudogene 59) is a **processed pseudogene** and not a functional protein-coding gene. It shares sequence similarity with RPL31, which encodes a component of the 60S ribosomal subunit involved in protein synthesis, but RPL31P59 itself does not encode a functional ribosomal protein[1][5][8]. There is no evidence in the literature that RPL31P59 functions as a therapeutic target, biomarker, or has established biological roles, disease associations, drug interactions, or safety concerns. Pseudogenes such as RPL31P59 are typically the result of gene duplication or retrotransposition events and may be transcribed in some cases, but they do not produce functional proteins and are not targets for drugs or therapies. **Additional details and clarification:** - **is_incorrect:** true — Because RPL31P59 is a pseudogene, not a protein, receptor, enzyme, transporter, or any entity that can be considered a classic "therapeutic target"[1][5][8]. Its identification as a target is likely due to confusion with the functional gene RPL31 or misunderstanding of pseudogene function. - **molecular_classifications:** Pseudogenes are classified as "other" and do not belong to major functional protein families (e.g., receptor, enzyme)[1][8]. - Most functional and drug-related information about ribosomal proteins pertains to RPL31 (ribosomal protein L31), not RPL31P59, and should not be conflated[3][4][7]. **Summary:** RPL31P59 should not be listed as a therapeutic or drug target. It is best viewed as a non-functional pseudogene related to the ribosomal protein RPL31. There is currently no validated biological, therapeutic, or disease-related function for this pseudogene.

Other names

RPL31_23_1580RPL31P59